Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Government minded to green light Gatwick expansion

(Sharecast News) - The UK government is poised to approve a second runway at Gatwick, it was confirmed on Thursday, just weeks after the chancellor back a similar expansion at Heathrow. In a written ministerial statement, transport secretary Heidi Alexander said she was "minded to approve" the £2.2bn construction project.

The Planning Inspectorate has recommended Gatwick's privately-financed proposal as it currently stands is rejected. But unusually, it said it would likely approve the application should changes be made, such as noise mitigation and agreeing what proportion of passengers should travel to the airport on public transport.

Alexander gave Gatwick a deadline of 24 April to tweak its plans, with a final decision now due on 27 October.

Situated around 30 miles south of London, Gatwick is currently Europe's busiest single runway airport, with more than 40m passengers using it last year. During busy periods, there can be 55 take-offs and landings an hour.

Gatwick wants to move its northern runway, which is currently only used for taxiing or as a back-up, and make fully operational by the end of the decade.

The airport, which unlike Heathrow is used predominantly for short-haul holiday destinations, believes the project will increase the number of departures by 50,000 a year by the end of the 2030s.

Unite, which represents 7,000 workers at Gatwick, backed the expansion, arguing that it would boost "highly skilled, well-paid, unionised jobs".

However, some environmental groups and residents are opposed to further expansion at Gatwick.

Last month Rachel Reeves cited the need to grow the economy as a core reason for backing a third runway at Heathrow, which has also faced similar opposition.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.